ARYA SCIENCES ACQUISITION CORP.

ARYA Sciences Acquisition Corp. (Nasdaq: ARYA), sponsored by Perceptive Advisors, is a blank-check company formed to pursue a business combination in the life sciences and healthcare sector. The company completed its initial public offering in 2019 and filed a Form 10-Q with the SEC on May 8, 2020, reflecting its status as a pre-combination entity actively evaluating acquisition candidates. Perceptive Advisors, a New York-based investment manager with deep expertise in biotechnology and healthcare, anchors the SPAC's management team and deal-sourcing strategy. The filing captures ARYA at an active stage of its search within the life sciences space. Sign up at SpacDesk for full filings, timeline data, and analytics on ARYA and the broader SPAC market.